Psychiatry AtlasMedication guide · United States

Antipsychotic medicine

Aripiprazole (Abilify)

Generic name
aripiprazole
Brand names
Abilify
Medication class
Antipsychotic medicine
Forms covered
oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

FDA Boxed Warning

oral tablets.

Older adults with dementia-related psychosis have an increased risk of death with antipsychotic treatment; Abilify is not approved for that condition. The oral Abilify label also warns of increased suicidal thoughts and behaviors in children, adolescents and young adults taking antidepressants. Monitor for worsening mood and suicidal thinking.

Aripiprazole (Abilify) treats schizophrenia and bipolar mania, and can be added to an antidepressant for adult depression. Its other approved uses include specified childhood irritability and tic conditions; this article covers oral tablets.

What to expect: Full benefit may take 2 weeks or longer.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Schizophrenia — Adults and adolescents aged 13–17. Treatment of schizophrenia, with ongoing reassessment of benefit.oral tablets.
  • Acute manic or mixed episodes in bipolar I disorder — Adults and children/adolescents aged 10–17. Acute monotherapy or adjunctive treatment with lithium or valproate; section 2.2 gives adult and age 10–17 dosing, while the pediatric combination indication is supported by extrapolation described in section 8.4.oral tablets.
  • Major depressive disorder, added to an antidepressant — Adults. Adjunctive treatment; this indication does not establish aripiprazole alone as an antidepressant treatment.oral tablets.
  • Irritability associated with autistic disorder — Children and adolescents aged 6–17. Targets specified irritability symptoms, not autism itself or every associated difficulty.oral tablets.
  • Tourette's disorder — Children and adolescents aged 6–18. Treatment of the disorder in the studied pediatric age range.oral tablets.

What should I expect?

Full benefit may take 2 weeks or longer. The intended change depends on the condition; feeling unable to sit still can be a side effect called akathisia and should not automatically be mistaken for worsening anxiety.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Take oral tablets once daily, with or without food, as prescribed. The dose depends on the condition, age, and interacting medicines. Long-acting injections have separate indications and starting and missed-dose procedures; do not convert from oral milligrams yourself.

Review weight, blood sugar, blood fats, blood pressure, movements, and mood. Tell the prescriber about low white-cell counts, seizures, swallowing problems, falls, or unusual urges. Avoid hazardous activities until you know how it affects you.

Do not use after a hypersensitivity reaction to aripiprazole.

Strong CYP2D6 inhibitors, including fluoxetine and paroxetine, and strong CYP3A4 inhibitors can increase aripiprazole exposure. Strong CYP3A4 inducers, such as carbamazepine, can lower it. The label contains specific dose adjustments, including different considerations for depression augmentation; do not apply a blanket dose rule yourself. Alcohol and other sedating medicines can worsen impairment, and blood-pressure medicines can add to dizziness or low blood pressure.

Pregnancy planning should consider both medication effects and relapse risk. Third-trimester antipsychotic exposure can cause newborn movement, feeding, breathing or withdrawal symptoms. Aripiprazole is present in breast milk and can substantially reduce milk production; clinicians should watch a breastfed infant for dehydration or poor weight gain. Pediatric approval differs by condition, and pediatric depression augmentation is not established. Older people may need additional attention to falls, swallowing and sensitivity to adverse effects.

Do not stop or change aripiprazole without discussing it with the prescriber. For a forgotten oral dose, follow the supplied instructions: take it when remembered unless it is nearly time for the next dose, and never double a dose. Repeated missed doses or a planned change to an injection warrant a specific clinician plan. The long half-life does not make unsupervised switching safe.

What side effects should I know about?

  • Nausea, constipation, headache, dizziness, insomnia or sleepiness can occur.
  • Akathisia (feeling unable to keep still), restlessness and anxiety are particularly important to recognize; weight or appetite changes also occur.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • New uncontrollable urges to gamble, shop, eat or engage in sexual behavior require prompt contact with the prescriber; family observations can be useful.
  • New or worsening suicidal thoughts, severe mood changes or dangerous impulses need prompt help; immediate danger needs emergency care.
  • Seek emergency care for high fever with severe stiffness or confusion, trouble breathing, collapse, a seizure, or a suspected overdose. New involuntary movements, severe restlessness, or symptoms of high blood sugar need prompt medical assessment.

What else should I know to stay safe?

  • Do not use after an allergic reaction to aripiprazole. Keep checks of weight, blood sugar, blood fats, blood pressure, movements, and mood. Review seizures, swallowing problems, falls, and low white-cell counts, which may require blood-count monitoring.
  • Fluoxetine, paroxetine, some antifungals or antivirals, carbamazepine, and other interacting medicines can change aripiprazole levels. Alcohol, sedatives, and blood-pressure medicines can add impairment or dizziness. Changes between tablets and injections, restarting, or stopping need a specific prescribing plan.
  • Discuss pregnancy and breastfeeding. Later-pregnancy exposure can cause newborn movement, feeding, breathing, or withdrawal problems. Aripiprazole can reduce milk production; an exposed infant needs attention to hydration and weight. Older adults need particular care with falls and swallowing.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • New urges to gamble, shop, eat, or engage in sexual activity can be a medication effect. Let the prescriber know; family observations may help identify a change.
  • If restlessness feels physical—as though you cannot keep still—describe that specifically. It can help the care team distinguish a movement side effect from the symptoms being treated.

How does it work?

Aripiprazole changes how brain cells respond to dopamine and serotonin, two chemical messengers. It partly activates some receptors, the proteins that receive these messages, while blocking others. Researchers know these actions occur, but the full connection between them and improvement in symptoms is still being worked out.

Explore more in Brain & Science: Partial Agonism: Aripiprazole.

How was this medicine developed?

Abilify tablets received FDA approval in 2002. Aripiprazole brought a partly activating action at dopamine receptors to the antipsychotic group. Later oral indications and separately developed injections have distinct requirements.

How do I say the name?

Aripiprazole: ay-rih-PIP-ray-zohl. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Abilify: current US prescribing information (1/2025)
  2. MedlinePlus: aripiprazole
  3. Drugs@FDA: Abilify approval and regulatory history
  4. Aripiprazole: FDA prescribing information
  5. Aripiprazole Tablets: Package Insert / Prescribing Info / MOA
  6. What Is a Neurotransmitter?
  7. PubChem: aripiprazole, CID 60795
  8. MedlinePlus: aripiprazole injection
  9. FDA: Seroquel immediate-release label and Medication Guide
  10. ISMP List of Confused Drug Names
  11. A qualitative investigation into the effects of akathisia - Health Research Authority
  12. Extrapyramidal side effects- Management
  13. Anxiety and panic attacks - NHS
  14. Agitation: MedlinePlus Medical Encyclopedia

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top